Key result
Serum magnesium shows no correlation with CIMT in hemodialysis patients.
Why the study?
Atherosclerosis progression is increased in ESRD patients and serum magnesium levels are associated with atherosclerosis in the carotid artery, but their protective role in vascular calcification and CIMT improvement is unclear.
Is serum magnesium level associated with carotid intima-media thickness in hemodialysis patients?
Cross-Sectional (n=81)
No
Is serum magnesium level associated with carotid intima-media thickness in hemodialysis patients?
Serum magnesium levels do not correlate with carotid intima-media thickness in hemodialysis patients, suggesting it may not be a protective factor for vascular calcification in this population.
Answers are grounded in this paper and cite their sources.
No support for magnesium as vascular protective factor in hemodialysis; leaves open its causal role in prospective trials.
Introduction: Atherosclerosis progression in the patients suffering from end-stage renal disease (ESRD) is more than normal population. Magnesium levels are also associated with an increase in atherosclerosis in the common carotid artery. Intima-media carotid calcification is either directly or indirectly related to cardiovascular disease and a higher rate of death among patients with chronic renal failure. Objectives: The purpose of the present study was to evaluate the protective role of serum magnesium levels in vascular calcification and the improvement of the carotid intima-media thickness (CIMT). Patients and Methods: In this cross-sectional research, the participants were selected from all patients with ESRD in Five Azar Medical Center of Gorgan, Iran. Blood samples collected from research units were tested for serum magnesium level in three times. Patients were referred to a radiologist to measure CIMT. Data collected in all patients were evaluated based on Spearman’s correlation test. Results: The correlation between serum magnesium level and CIMT was not statistically significant (P = 0.66 r= 0.04), however a positive correlation between CIMT and the dialysis adequacy (KT/V) was detected (r = 0.306, P = 0.006). Conclusion: This study demonstrated no correlation between the serum magnesium level and the CIMT in hemodialysis patients.
No takes yet. Share an insight, caveat, or question.
Esmaili et al. (2021) conducted a cross-sectional in End-stage renal disease on hemodialysis (n=81). Serum magnesium level was evaluated on Correlation between serum magnesium level and carotid intima-media thickness (CIMT) (r=0.04, p=0.66). Serum magnesium levels showed no significant correlation with carotid intima-media thickness in patients undergoing hemodialysis.
Synapse has enriched 10 related papers. Consider them for comparative context: